Primary angle-closure glaucoma Eye Diseases Glaucoma
Conditions
Interventions
Sponsors
Ellex Medical Pty. Ltd. (Australia)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. PACG 2. Intraocular pressure 21 - 28 mmHg on one or more topical medicine in presence of patent iridotomy 3. At least two months since last iridotomy 4. Aged over 21 years old
Exclusion criteria
Exclusion criteria: 1. Secondary causes of angle-closure 2. Corneal abnormalities 3. Advanced glaucomatous optic neuropathy 4. Patient blind in one eye
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure (IOP) at regular intervals of follow-up with the final IOP being measured at six months after the last treatment. Successful outcome defined as greater or equal to 20% reduction in IOP from pre-laser levels. | — |
Secondary
| Measure | Time frame |
|---|---|
| IOP measured on other eye if both eyes are eligible for the study. | — |
Countries
Hong Kong, Philippines, Singapore, Thailand
Outcome results
None listed